Katharina Schallmoser

The Fc gammaRIIa polymorphism R/H131, autoantibodies against the platelet receptors GPIb alpha and Fc gammaRIIa and a risk for thromboembolism in lupus anticoagulant patients.

Immune cells mimic the morphology of endothelial progenitor colonies in vitro.

Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.

Two steps to functional mesenchymal stromal cells for clinical application.

Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.

Thrombin generation before and after multicomponent blood collection.

Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.

The particle gel immunoassay as a rapid test to rule out heparin-induced thrombocytopenia?

Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.

Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.

Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells.

Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions.

Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation.

Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells.

Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate.

Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.